Travv
Category: AI in Healthcare
AI-native veterinary diagnostics platform spanning radiology, cardiology, and cloud PACS/RIS with validated AI measurement tools Travv was founded in 2025. The company is led by Derick Whitley. Based in Stillwater, Oklahoma. Team size: 2-10. Total funding raised: $1.6M. Latest round: Seed. Key investors include Digitalis Ventures; AniVC.
- Founded
- 2025
- Headquarters
- Stillwater, Oklahoma
- Team size
- 2-10
- Total funding
- $1.6M
Value proposition
Travv is building modern AI-native infrastructure for veterinary diagnostics, integrating RIS, PACS, and LIS capabilities into a single cloud-based platform that connects veterinarians with expert diagnosticians while using AI to streamline workflows.
Products and solutions
Travv Dx (AI-native cloud PACS+RIS), Travv Rads (board-certified teleradiology, STAT/standard), Travv Cardio (live telecardiology—echo/ECG/consults), Free VHS/VLAS AI cardiac measurement tool (PLOS ONE-validated, MetronMind models), Cloud PACS with PIMS integrations (ezyVet, Cornerstone), Pipeline of novel cloud-based diagnostics
Unique value
AI-first integrated diagnostic platform purpose-built for veterinary medicine, combining cloud-based RIS/PACS/LIS with AI-powered workflow automation and expert diagnostician network — replacing fragmented legacy systems with a unified modern experience.
Target customer
Veterinary hospitals and clinics; veterinary diagnosticians (radiologists, pathologists); veterinary telemedicine providers
Industries served
Veterinary Medicine; Animal Health; Veterinary Diagnostics; Veterinary Radiology
Technology advantage
AI-native architecture from day one; cloud PACS+RIS unifies radiology/cardiology workflows with PIMS integration; peer-reviewed VHS/VLAS deep-learning models (PLOS ONE 2026; MetronMind assets; 11k+ training radiographs, 40k+ real-world images); team of board-certified pathologists/radiologists plus dedicated ML leadership (John Craig); MCP-ready telemed tooling.
How they differentiate
Unlike SignalPET and Vetology which focus primarily on AI radiology interpretation, Travv is building a broader integrated diagnostic platform (RIS/PACS/LIS) with AI woven throughout, plus offering teleradiology services and data annotation. Travv's team brings deep veterinary pathology and radiology expertise alongside AI engineering talent.
Main competitors
SignalPET, Vetology AI, Zoetis (Vetscan Imagyst)
Key partnerships
PIMS integrations live with ezyVet and IDEXX Cornerstone, acquired MetronMind veterinary imaging AI assets (VHS/VLAS models developed by John Craig), cardiology specialist network including Dr. Brittany Stewart / AllHearts, conference sponsorships (SAVY 3.0 Cornell May 2026, AVDC China 2026)
Major milestones
Founded 2025, Launched radiology service and Cloud PACS early 2026, VMX 2026 presence, Closed $1.6M seed led by Digitalis Ventures (May 2026), Sponsored SAVY 3.0 at Cornell (May 2026), Hired John Craig, PhD as Director of ML / integrated MetronMind VHS-VLAS AI assets (Jun 2026), Launched Travv Cardio, Presented at AVDC 2026 Zhengzhou (Jul 2026), PLOS ONE validation of cardiac measurement models (Jul 2026)
Market positioning
Early-stage entrant in the veterinary AI diagnostics market, competing against established players (IDEXX, Zoetis, Antech) and AI-native startups (SignalPET, Vetology). Positioned as an integrated platform company rather than a point-solution AI tool.
Geographic focus
US (headquartered in Stillwater, Oklahoma); global ambitions with international advisor for Asia market
About Derick Whitley
Ex-Chief Medical Officer / VP Strategy, Innovation & Diagnostics at Vidium Animal Health (led to exit in 2024); ~9 years at Antech Diagnostics incl. Assistant Chief of Anatomic Pathology—led large-scale digital pathology conversion and early commercial CV models. DVM Oklahoma State; DACVP. Adjunct faculty at TGen and Oklahoma State University.
Latest news about Travv
More AI in Healthcare companies
Official website: https://travv.com